Multiple Sclerosis Clinical Trial

Next-Gen MS: Feed-forward PRO Data for MS Research

Summary

This Next Generation learning health system for Multiple Sclerosis (Next-Gen MS) study is a sub-study of the MS-LINKâ„¢ Outcomes Study (NCT04735406). The study aims to examine the effects of using feed forward Patient Reported Outcomes (PROs) data in real-world Multiple Sclerosis (MS) care settings. The study will be conducted within an emerging Learning Healthcare System (LHS).

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Participants willing and able to provide written informed consent
Participants with clinical diagnosis of Multiple Sclerosis (MS)

Exclusion Criteria:

None

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

2000

Study ID:

NCT04907305

Recruitment Status:

Recruiting

Sponsor:

EMD Serono Research & Development Institute, Inc.

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 8 Locations for this study

See Locations Near You

Alabama Neurology Associates
Birmingham Alabama, 35209, United States
Georgetown University
Washington District of Columbia, 20057, United States
Atlanta Neuroscience Institute
Atlanta Georgia, 30327, United States
Beth Israel Deaconess Medical Center
Boston Massachusetts, 02215, United States
The Memorial Hospital, d.b.a Memorial Healthcare
Owosso Michigan, 48867, United States
Oklahoma Medical Research Foundation
Oklahoma City Oklahoma, 73104, United States
The University of Texas of Austin
Austin Texas, 78759, United States
The University of Texas Health Science Center
San Antonio Texas, 78229, United States

How clear is this clinincal trial information?

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

2000

Study ID:

NCT04907305

Recruitment Status:

Recruiting

Sponsor:


EMD Serono Research & Development Institute, Inc.

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.